Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | MMP9 | P14780 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3182522 | 0.98 | GAA (0.64) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL31169783 | 0.98 | GAA (0.64) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL5854983 | 0.95 | GAA (0.61) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL15301365 | 0.81 | GAA (0.67) | GAASMN1; SMN2CA1CA2MMP1 | |
| Styrene SCHEMBL28501274 | 0.79 | CA12 (0.50) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL28678466 | 0.79 | GAA (0.95) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL29658990 | 0.79 | ALDH1A1 (0.67) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL187561 | 0.78 | GAA (0.70) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL7627224 | 0.78 | ALDH1A1 (0.72) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL2242608 | 0.77 | GAA (0.61) | GAASMN1; SMN2CA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4146496-A | ALKALI METAL N-BROMO ARYL SULFONAMIDE PROMOTER | COLGATE-PALMOLIVE COMPANY (US) | 1979-03-27 | — | — | US | claimed |
| US-7662969-B2 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2010-02-16 | — | — | US | disclosed |
| US-20060211870-A1 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | THE UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211870-A1 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | RPL24, RPL26, ZDHHC20 | GAA 3331/4885SMN1; SMN2 4580/4885CA1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.